Features | Partner Sites | Information | LinkXpress
Sign In
FOCUS DIAGNOSTICS, INC.
RANDOX LABORATORIES
GLOBETECH PUBLISHING

Key Genetic Error Found in Blood Cancer Groups

By Labmedica International staff writers
Posted on 12 Jan 2012
A critical genetic mutation has been revealed in some patients within a family of blood cancers that can progress to a fatal form of leukemia.

This family of blood cancers is known as myelodysplastic syndromes and are a difficult-to-treat type of blood disease that occur when blood cells in the bone marrow do not mature properly.

A scientific team at the Washington University School of Medicine (St. Louis, MO, USA) discovered the mutation in a gene known as small nuclear ribonucleic acid (RNA) auxiliary factor 1(U2AF1). They sequenced the entire genome of a 65-year old man with myelodysplastic syndrome that had progressed to leukemia and compared it with the genome of his tumor cells.

After identifying the U2AF1 mutation in three patients through whole-genome sequencing, the investigators scoured the gene for the mutation in another 150 patients with myelodysplastic syndromes. They identified the mutation in 13, or nearly 9% of the patients. The mutations were acquired during development of myelodysplastic syndromes because they were not present in normal cells obtained from each patient. Patients were almost three times as likely to develop leukemia if they had a mutation in the U2AF1 gene. The disorder progressed to leukemia in 15.2% of patients with the mutation, compared with 5.8% of those without the genetic anomaly.

Normally, the U2AF1 gene makes a protein involved in splicing RNA, a sister molecule of DNA that carries the instructions for building proteins. Splicing brings together different sections of RNA necessary to make a protein and discards those sections that are not needed. The mutated version of the gene still produces a protein, but its splicing activity is altered, which may be important for the development of some cancers.

Timothy Graubert, MD, an associate professor of medicine and senior author of the study said, "A mutation in any one of these eight genes occurs in up to 50% of patients with myelodysplastic syndromes. Because these changes are so common, we think there are likely to be implications for improving the diagnosis of the disorder and finding new therapeutic options." Myelodysplastic syndromes are hematopoietic stem cell disorders that often progress to chemotherapy-resistant secondary acute myeloid leukemia. About 28,000 Americans are diagnosed with the disorder each year, most of them over the age of 60. The study was published on December 11, 2011, in the journal Nature Genetics.

Related Links:
Washington University School of Medicine



DiagCor Bioscience
Sekisui Diagnostics
VIRCELL
comments powered by Disqus
Life Technologies

Channels

Clinical Chemistry

view channel

Red Blood Cell Folate Level Is a Biomarker for Risk of Neural Tube Defects

The importance of maintaining high red blood cell (RBC) levels of folate during pregnancy to reduce risk of neural tube defects was confirmed in a review of results obtained by a large study of expectant mothers in China. A team of American and Chinese researchers worked with results obtained from 247,831 participants... Read more

Microbiology

view channel
Image: The adult free-living female Strongyloides stercoralis with a row of eggs within the body of the nematode (Photo courtesy of the CDC - Centers for Disease Control and Prevention).

Rapid Serological Assay Developed for Strongyloidiasis

Several imperfect methods exist for diagnosing strongyloidiasis and stool examination with microscopic identification of larvae considered the gold standard diagnostic procedure, showing good specificity... Read more

Pathology

view channel
Image: The BD Viper LT System for fully automated, integrated molecular testing on a table top analyzer (Photo courtesy of BD Diagnostics).

Modern Methods Accurately Detects Cervical Cancer

The newer Papanicolaou test (Pap tests) and human papilloma virus (HPV) screening more accurately identify precancerous cellular changes that potentially develop into cervical cancer. Compared to a... Read more

Lab Tech.

view channel
Image: RNAscope detects TP63 mRNA expression in human prostate tissue (Photo courtesy of Advanced Cell Diagnostics).

RNA Biomarker Assay Now Manufactured According to Strict ISO Regulatory Criteria

A line of diagnostic kits that measures RNA biomarkers with single-molecule sensitivity is now being manufactured under the stringent requirements of ISO 13485:2003 certification. Advanced Cell Diagnostics, Inc.... Read more

Industry News

view channel

Social Diagnostics Start-Up to Provide Simple, Affordable Tests Worldwide

The Royal Tropical Institute (KIT; Amsterdam, Netherlands) is establishing a nonprofit, social diagnostics company that develops and markets tests for the diagnosis of poverty-related diseases. Infectious diseases have a global impact; they take no account of national borders and influence the stability of societies... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.